Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome

被引:21
|
作者
Yang, Wan [1 ]
Yang, Rui [1 ]
Lin, Mingmei [1 ]
Yang, Yan [1 ]
Song, Xueling [1 ]
Zhang, Jiajia [1 ]
Yang, Shuo [1 ]
Song, Ying [1 ]
Li, Jia [1 ]
Pang, Tianshu [1 ]
Deng, Feng [1 ]
Zhang, Hua [2 ]
Wang, Ying [1 ]
Li, Rong [1 ]
Jiao, Jie [1 ]
机构
[1] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, 49 N Garden Rd, Beijing 100191, Peoples R China
[2] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Gonadotropin-releasing hormone antagonist; Polycystic ovary syndrome; Hyperandrogenism; Body mass index; In vitro fertilization; IN-VITRO FERTILIZATION; WOMEN; PCOS; INFERTILITY; EXPRESSION; CONSENSUS; OUTCOMES; OOCYTE; IVF;
D O I
10.1186/s12958-018-0438-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThere is limited literature investigating the effects of body mass index (BMI) and androgen level on in vitro fertilization (IVF) outcomes with a gonadotropin-releasing hormone (GnRH)-antagonist protocol in polycystic ovary syndrome (PCOS). Androgen-related variation in the effect of body mass index (BMI) on IVF outcomes remains unknown.MethodsIn this retrospective study, 583 infertile women with PCOS who underwent IVF using the conventional GnRH-antagonist protocol were included. Patients were divided into four groups according to BMI and androgen level: overweight- hyperandrogenism(HA) group, n=96, overweight-non-HA group, n=117, non-overweight-HA group, n=152, and non-overweight-non-HA group, n=218.ResultsA significantly higher number of oocytes were retrieved, and the total Gn consumption as well Gn consumption per day was significantly lower, in the non-overweight groups than in the overweight groups. The number of available embryos was significantly higher in the HA groups than in the non-HA groups. Clinical pregnancy rate was of no significant difference among four groups. Live-birth rates in the overweight groups were significantly lower than those in non-overweight-non-HA group (23.9, 28.4% vs. 42.5%, P<0.05). The miscarriage rate in overweight-HA group was significantly higher than that in non-overweight-non-HA group (45.2% vs. 14.5%, P<0.05). Multivariate logistic regression analysis revealed that BMI and basal androstenedione (AND) both acted as significantly influent factors on miscarriage rate. The area under the curve (AUC) in receiver operating characteristic (ROC) analysis for BMI and basal AND on miscarriage rate were 0.607 (P=0.029) and 0.657 (P=0.001), respectively, and the cut-off values of BMI and basal AND were 25.335kg/m(2) and 10.95nmol/L, respectively.ConclusionsIn IVF cycles with GnRH-antagonist protocol, economic benefits were seen in non-overweight patients with PCOS, with less Gn cost and more retrieved oocytes. BMI and basal AND were both significantly influential factors with moderate predictive ability on the miscarriage rate. The predictive value of basal AND on miscarriage was slightly stronger than BMI.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
    Wan Yang
    Rui Yang
    Mingmei Lin
    Yan Yang
    Xueling Song
    Jiajia Zhang
    Shuo Yang
    Ying Song
    Jia Li
    Tianshu Pang
    Feng Deng
    Hua Zhang
    Ying Wang
    Rong Li
    Jie Jiao
    [J]. Reproductive Biology and Endocrinology, 16
  • [2] Decreased Adiponectin Levels in Polycystic Ovary Syndrome, Independent of Body Mass Index
    Sharifi, Faranak
    Hajihosseini, Reza
    Mazloomi, Sahar
    Amirmogaddami, Hamidreza
    Nazem, Habibollah
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (01) : 47 - 51
  • [3] Birthweight, Childhood Body Mass Index, Height and Growth, and Risk of Polycystic Ovary Syndrome
    Aarestrup, Julie
    Pedersen, Dorthe C.
    Thomas, Peter E.
    Glintborg, Dorte
    Holm, Jens-Christian
    Bjerregaard, Lise G.
    Baker, Jennifer L.
    [J]. OBESITY FACTS, 2021, 14 (03) : 283 - 290
  • [4] Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index
    Garoufi, Anastasia
    Pagoni, Athanasia
    Papadaki, Maria
    Marmarinos, Antonios
    Karapostolakis, Georgios
    Michala, Lina
    Soldatou, Alexandra
    [J]. CHILDREN-BASEL, 2022, 9 (01):
  • [5] Adrenal Androgen Excess and Body Mass Index in Polycystic Ovary Syndrome
    Moran, Carlos
    Arriaga, Monica
    Arechavaleta-Velasco, Fabian
    Moran, Segundo
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (03): : 942 - 950
  • [6] Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy
    Lonnebotn, Marianne
    Natvig, Gerd Karin
    Benediktsdottir, Bryndis
    Burgess, John A.
    Holm, Mathias
    Jogi, Rain
    Lindberg, Eva
    Macsali, Ferenc
    Schlunssen, Vivi
    Skulstad, Svein Magne
    Franklin, Karl A.
    Vanky, Eszter
    Real, Francisco Gomez
    [J]. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 11 : 32 - 37
  • [7] Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
    Abu Saleh Md Moin
    Thozhukat Sathyapalan
    Alexandra E. Butler
    Stephen L. Atkin
    [J]. Journal of Translational Medicine, 19
  • [8] Vitamin D association with coagulation factors in polycystic ovary syndrome is dependent upon body mass index
    Moin, Abu Saleh Md
    Sathyapalan, Thozhukat
    Butler, Alexandra E.
    Atkin, Stephen L.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [9] Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome
    Li, Jian
    Wu, Qi
    Wang, Chi Chiu
    Wang, Rui
    Ng, Ernest H. Y.
    Liu, Jian-Ping
    Mol, Ben Willem J.
    Wu, Xiao-Ke
    Li, Wen-Tao
    Kuang, Hong-Ying
    Ma, Hong-Li
    Gao, Jing-Shu
    Xie, Liang-Zhen
    Hou, Li-Hui
    Hu, Zhen-Xing
    Shao, Xiao-Guang
    Ge, Jun
    Zhang, Jin-Feng
    Xue, Hui-Ying
    Xu, Xiao-Feng
    Liang, Rui-Ning
    Ma, Hong-Xia
    Yang, Hong-Wei
    Huang, Dong-Mei
    Sun, Yun
    Hao, Cui-Fang
    Du, Shao-Min
    Ding, Cai-Fei
    Gao, Ya-Qin
    Wu, Tai-Xiang
    Stener-Victorin, Elisabet
    Zhang, Heping
    Legro, Richard S.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 39 (05) : 868 - 876
  • [10] Body Mass Index as a Predictor of Polycystic Ovary Syndrome Risk: Results of a Longitudinal Cohort Study.
    Teede, H. J.
    Deeks, A. A.
    Gibson-Helm, M.
    Lombard, C.
    Jolley, D.
    Paul, E.
    Loxton, D.
    Moran, L.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)